Incidence and factors associated with adverse drug reactions in a cohort of individuals starting dolutegravir or efavirenz . Research, Society and Development, [S. l.], v. 11, n. 4, p. e0811426250, 2022. DOI: 10.33448/rsd-v11i4.26250. Disponível em: https://rsdjournal.org/rsd/article/view/26250. Acesso em: 5 dec. 2025.